Atom | Limited Competition: Competing Revisions to Support Clinical Trials in Somatic Cell Genome Editing (U19 Clinical Trial Required)

Due Dates: May 29, 2025 | September 26, 2025 | February 13, 2026 | May 29, 2026

Funding Amounts: No set budget limit; up to 3 years; up to 2 awards; additional $2.6M may be available per awardee.

Summary: Limited competition for U19 awardees to expand to first-in-human somatic cell genome editing clinical trials using candidates developed under prior NIH funding.

Key Information: Only current U19 awardees from RFA-RM-22-015 are eligible; clinical trial and pre-IND meeting required.

Limited Competition: Competing Revisions to Support Clinical Trials in Somatic Cell Genome Editing (U19 Clinical Trial Required)

Sign in to see full grant listing